Aperio Group’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$20.2M Sell
1,111,580
-132,202
-11% -$2.41M 0.06% 308
2020
Q3
$22.2M Buy
1,243,782
+213,340
+21% +$3.81M 0.07% 249
2020
Q2
$18.5M Buy
1,030,442
+279,898
+37% +$5.02M 0.07% 279
2020
Q1
$11.4M Sell
750,544
-264,687
-26% -$4.02M 0.05% 371
2019
Q4
$20M Buy
1,015,231
+187,958
+23% +$3.71M 0.07% 293
2019
Q3
$14.2M Buy
827,273
+229,309
+38% +$3.94M 0.06% 370
2019
Q2
$10.6M Sell
597,964
-284,447
-32% -$5.03M 0.04% 457
2019
Q1
$18M Buy
882,411
+643,224
+269% +$13.1M 0.08% 287
2018
Q4
$4.02M Buy
+239,187
New +$4.02M 0.02% 723
2014
Q2
Sell
-290,284
Closed -$6.9M 1755
2014
Q1
$6.9M Buy
+290,284
New +$6.9M 0.1% 264
2013
Q4
Sell
-235,055
Closed -$5.55M 255
2013
Q3
$5.55M Buy
235,055
+30,386
+15% +$718K 0.11% 236
2013
Q2
$4.62M Buy
+204,669
New +$4.62M 0.11% 228